These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36681363)

  • 1. Lamprey prohibitin 2 inhibits non-small cell lung carcinoma cell proliferation by down-regulating the expression and phosphorylation levels of cell cycle-associated proteins.
    Zhang X; Zhao J; Li Q; Qin D; Li W; Wang X; Bi M; Li Q; Li T
    Fish Shellfish Immunol; 2023 Mar; 134():108560. PubMed ID: 36681363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamprey Prohibitin2 Arrest G2/M Phase Transition of HeLa Cells through Down-regulating Expression and Phosphorylation Level of Cell Cycle Proteins.
    Shi Y; Guo S; Wang Y; Liu X; Li Q; Li T
    Sci Rep; 2018 Mar; 8(1):3932. PubMed ID: 29500418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prohibitin 2/PHB2 in Parkin-Mediated Mitophagy: A Potential Therapeutic Target for Non-Small Cell Lung Carcinoma.
    Zhang H; Yin C; Liu X; Bai X; Wang L; Xu H; Ju J; Zhang L
    Med Sci Monit; 2020 Apr; 26():e923227. PubMed ID: 32320388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterisation of the anti-oxidative stress properties of the lamprey prohibitin 2 gene.
    Li T; Wang Y; Gao Y; Li Q
    Fish Shellfish Immunol; 2015 Feb; 42(2):447-56. PubMed ID: 25463290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHB2 promotes tumorigenesis
    Wu B; Chang N; Xi H; Xiong J; Zhou Y; Wu Y; Wu S; Wang N; Yi H; Song Y; Chen L; Zhang J
    Theranostics; 2021; 11(7):3150-3166. PubMed ID: 33537079
    [No Abstract]   [Full Text] [Related]  

  • 6. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
    Xu X; Jiang J; Yao L; Ji B
    Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamprey PHB2 maintains mitochondrial stability by tanslocation to the mitochondria under oxidative stress.
    Shi Y; Li Q; Sun F; Zhu C; Ma S; Qin D; Li Q; Li T
    Fish Shellfish Immunol; 2020 Sep; 104():613-621. PubMed ID: 32592929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of Cyclin B1 mediates nagilactone E-induced G2 phase cell cycle arrest in non-small cell lung cancer cells.
    Zhang LL; Feng ZL; Su MX; Jiang XM; Chen X; Wang Y; Li A; Lin LG; Lu JJ
    Eur J Pharmacol; 2018 Jul; 830():17-25. PubMed ID: 29680228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing expression of Prohibitin-2 lowers the oncogenicity of renal cell carcinoma cells by suppressing eIF4E-mediated oncogene translation via MNK inhibition.
    Yang J; Li G; Huang Y; Liu Y
    Toxicol Appl Pharmacol; 2023 May; 466():116458. PubMed ID: 36931439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
    Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
    BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The survival and proliferation of osteosarcoma cells are dependent on the mitochondrial BIG3-PHB2 complex formation.
    Toki S; Yoshimaru T; Matsushita Y; Aihara H; Ono M; Tsuneyama K; Sairyo K; Katagiri T
    Cancer Sci; 2021 Oct; 112(10):4208-4219. PubMed ID: 34363714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells.
    Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J
    Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antisense RNA targeting polo-like kinase 1 on cell cycle and proliferation in A549 cells.
    Zhou Q; Bai M; Su Y
    Chin Med J (Engl); 2004 Nov; 117(11):1642-9. PubMed ID: 15569479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CacyBP promotes the proliferation and invasion of non-small cell lung cancer].
    Xu YJ; Hu YM; Qin C; Wang F; Cao W; Yu YW; Zhao L; Li J; Chen WQ; Li N; He J
    Zhonghua Zhong Liu Za Zhi; 2021 Sep; 43(9):924-931. PubMed ID: 34530574
    [No Abstract]   [Full Text] [Related]  

  • 15. Knockdown of Immature Colon Carcinoma Transcript 1 Inhibits Proliferation and Promotes Apoptosis of Non-Small Cell Lung Cancer Cells.
    Wang Y; He J; Zhang S; Yang Q; Wang B; Liu Z; Wu X
    Technol Cancer Res Treat; 2017 Oct; 16(5):559-569. PubMed ID: 27413166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of nucleolin is indispensable to its involvement in the proliferation and migration of non-small cell lung cancer cells.
    Huang F; Wu Y; Tan H; Guo T; Zhang K; Li D; Tong Z
    Oncol Rep; 2019 Jan; 41(1):590-598. PubMed ID: 30320343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prohibitin 2: A key regulator of cell function.
    Zhang B; Li W; Cao J; Zhou Y; Yuan X
    Life Sci; 2024 Feb; 338():122371. PubMed ID: 38142736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of lncRNA X inactive specific transcript (XIST) radiosensitizes non-small cell lung cancer (NSCLC) cells through regulation of miR-16-5p/WEE1 G2 checkpoint kinase (WEE1) axis.
    Du R; Jiang F; Yin Y; Xu J; Li X; Hu L; Wang X
    Int J Immunopathol Pharmacol; 2021; 35():2058738420966087. PubMed ID: 33583218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of antisense RNA targeting Polo-like kinase 1 on cell cycle of lung cancer cell line A549].
    Zhou Q; Bai M; Su Y
    Ai Zheng; 2005 Feb; 24(2):149-54. PubMed ID: 15694023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SP1-regulated LINC01638 promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
    Guo L; Fang L; Liu Y
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8913-8920. PubMed ID: 31696478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.